The study was funded by GSK and Valeant Pharmaceuticals International, and all of the investigators are employees of either company.
Conference Coverage
Urinary Dysfunction Stands Out on Retigabine's Safety Profile
Publish date: December 20, 2011
FROM THE ANNUAL MEETING OF THE AMERICAN EPILEPSY SOCIETY